Growth Metrics

Bioregenx (BRGX) Notes Payables (2022 - 2026)

Bioregenx's quarterly Notes Payables came in at $952615.0 in Q1 2026, up 8.15% year-on-year from $880796.0 in Q1 2025, and down 5.04% quarter-over-quarter from $1.0 million in Q4 2025.

Bioregenx has reported Notes Payables for 5 years, with the latest figure at $952615.0 in Q1 2026.

  • For the quarter ending Q1 2026, Notes Payables rose 8.15% year-over-year to $952615.0; the trailing twelve-month figure through Mar 2026 stood at $952615.0 (up 8.15% YoY), and the FY2025 full-year result was $1.0 million, up 13.58% from the prior year.
  • Notes Payables for Q1 2026 stood at $952615.0, down from $1.0 million in the prior quarter.
  • The five-year high for Notes Payables was $1.0 million in Q3 2025, with the low at $12590.0 in Q1 2023.
  • Average Notes Payables over 5 years is $626202.3, with a median of $863144.0 recorded in 2024.
  • Year-over-year, Notes Payables surged 6657.85% in 2024 and grew 3.69% in 2025.
  • Tracing BRGX's Notes Payables over 5 years: stood at $40970.0 in 2022, then surged by 816.97% to $375681.0 in 2023, then jumped by 135.11% to $883271.0 in 2024, then increased by 13.58% to $1.0 million in 2025, then retreated by 5.04% to $952615.0 in 2026.
  • The last three Notes Payables figures came in at $952615.0 (Q1 2026), $1.0 million (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Bioregenx - - 348,288.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 952,615.00
Dec 31, 2025 1.00 Mn
Sep 30, 2025 1.04 Mn
Jun 30, 2025 970,117.00
Mar 31, 2025 880,796.00
Dec 31, 2024 883,271.00
Sep 30, 2024 875,475.00
Jun 30, 2024 850,813.00
Mar 31, 2024 849,491.00
Dec 31, 2023 375,681.00
Sep 30, 2023 14,390.00
Jun 30, 2023 12,590.00
Mar 31, 2023 12,590.00
Dec 31, 2022 40,970.00